Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Change in Account Payables (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Change in Account Payables for 3 consecutive years, with -$467000.0 as the latest value for Q4 2025.

  • Quarterly Change in Account Payables rose 45.44% to -$467000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.0 million through Dec 2025, down 711.9% year-over-year, with the annual reading at -$1.0 million for FY2025, 711.9% down from the prior year.
  • Change in Account Payables hit -$467000.0 in Q4 2025 for Camp4 Therapeutics, up from -$546000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.1 million in Q3 2024 to a low of -$1.0 million in Q2 2024.
  • Historically, Change in Account Payables has averaged -$112222.2 across 3 years, with a median of -$190000.0 in 2025.
  • Biggest five-year swings in Change in Account Payables: plummeted 470.67% in 2024 and later skyrocketed 81.8% in 2025.
  • Year by year, Change in Account Payables stood at -$150000.0 in 2023, then tumbled by 470.67% to -$856000.0 in 2024, then surged by 45.44% to -$467000.0 in 2025.
  • Business Quant data shows Change in Account Payables for CAMP at -$467000.0 in Q4 2025, -$546000.0 in Q3 2025, and -$190000.0 in Q2 2025.